Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Strasser

Showing results (281-290 of 320) with videos related to

Pageof 32
Sort By:
EMBO Reports|April 30, 2025
Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformationErin M Lawrence, Amali Cooray, Andrew J Kueh, et al.
Cell Death & Disease|April 26, 2019
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survivalErinna F Lee, Tiffany J Harris, Sharon Tran, et al.
Molecular Cell|May 22, 2012
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunityRune Busk Damgaard, Ueli Nachbur, Monica Yabal, et al.
Nature Medicine|June 13, 2018
DNA repair processes are critical mediators of p53-dependent tumor suppressionAna Janic, Liz J Valente, Matthew J Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1Ben A Croker, Joanne A O'Donnell, Cameron J Nowell, et al.
Cell Death and Differentiation|April 1, 2017
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivoEmma M Carrington, Yifan Zhan, Jamie L Brady, et al.
Nature Immunology|July 16, 2013
Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cellsWim Pierson, Bénédicte Cauwe, Antonia Policheni, et al.
The Journal of Experimental Medicine|January 7, 2017
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survivalCharlotte Viant, Sophie Guia, Robert J Hennessy, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Nature Communications|March 23, 2025
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regenerationHui San Chin, Jinming Cheng, Shih Han Hsu, et al.
Pageof 32

Showing results (281-290 of 320) with videos related to

Sort By:
Pageof 32
EMBO Reports|April 30, 2025
Transcriptomic changes including p53 dysregulation prime DNMT3A mutant cells for transformationErin M Lawrence, Amali Cooray, Andrew J Kueh, et al.
Cell Death & Disease|April 26, 2019
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survivalErinna F Lee, Tiffany J Harris, Sharon Tran, et al.
Molecular Cell|May 22, 2012
The ubiquitin ligase XIAP recruits LUBAC for NOD2 signaling in inflammation and innate immunityRune Busk Damgaard, Ueli Nachbur, Monica Yabal, et al.
Nature Medicine|June 13, 2018
DNA repair processes are critical mediators of p53-dependent tumor suppressionAna Janic, Liz J Valente, Matthew J Wakefield, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 20, 2011
Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1Ben A Croker, Joanne A O'Donnell, Cameron J Nowell, et al.
Cell Death and Differentiation|April 1, 2017
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivoEmma M Carrington, Yifan Zhan, Jamie L Brady, et al.
Nature Immunology|July 16, 2013
Antiapoptotic Mcl-1 is critical for the survival and niche-filling capacity of Foxp3⁺ regulatory T cellsWim Pierson, Bénédicte Cauwe, Antonia Policheni, et al.
The Journal of Experimental Medicine|January 7, 2017
Cell cycle progression dictates the requirement for BCL2 in natural killer cell survivalCharlotte Viant, Sophie Guia, Robert J Hennessy, et al.
Cell Death and Differentiation|October 25, 2019
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Rachel Cartlidge, Catherine Chang, et al.
Nature Communications|March 23, 2025
MCL‑1 safeguards activated hair follicle stem cells to enable adult hair regenerationHui San Chin, Jinming Cheng, Shih Han Hsu, et al.
Pageof 32